14 Jul 2010 18:52
Veropharm to boost net profit 90% in Q1
MOSCOW. July 14 (Interfax) - Russian pharmaceuticals maker Veropharm will post a net profit of $6.9 million in the first quarter of 2010 under International Financial Reporting Standards (IFRS), 90% more than in the same period last year, analysts at investment companies and banks told Interfax in a consensus forecast.
Revenue will rise 26% to $33.9 million, they said.
EBITDA is forecast to increase 80% to $10 million.
Veropharm will publish IFRS results for the first quarter on July 15.
Forecast indicators for Veropharm in Q1 2010 ($ mln):
| Company | Revenue | EBITDA | Net profit |
| RMG | 34.5 | 11.1 | 8.1 |
| TCB Capital | 36.8 | 10.8 | 6.9 |
| Otkritie | 32.8 | 9.5 | 6.9 |
| BKS | 31.5 | 8.5 | 5.8 |
| Consensus | 33.9 | 10 | 6.9 |
| 2009 actual | 26.9 | 5.6 | 3.7 |
| Change (%) | 26 | 78.1 | 87.2 |
RTS$#&: VRPH